Share
Other content recommended for you
- Protective lipid-lowering variants in healthy older individuals without coronary heart disease
- Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disorders
- Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study
- Practice guideline: joint CCMG-SOGC recommendations for the use of chromosomal microarray analysis for prenatal diagnosis and assessment of fetal loss in Canada
- Clinical application of fetal genome-wide sequencing during pregnancy: position statement of the Canadian College of Medical Geneticists
- Guideline for feedback of individual genetic research findings for genomics research in Africa
- Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel
- AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol
- Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)
- Taking it to the bank: the ethical management of individual findings arising in secondary research